Fiche société
Clinical Nutrition Research Center, Illinois Institute of Technology
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| GSEBP — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk FactorsInflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects of taking 150mg of MegaNatural BP GSE per day on blood pressure levels along with influences on heart health through assessing the function of the blood vessel lining and levels of inflammation. | Hypertension | Non applicable | Immunomodulation | United States | À vérifier |
| GSEBP — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk FactorsInflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects of taking 150mg of MegaNatural BP GSE per day on blood pressure levels along with influences on heart health through assessing the function of the blood vessel lining and levels of inflammation. | Hypertension | Non applicable | Immunomodulation | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| GSEBP — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors | Hypertension | Non applicable | NCT06555952 | GSEBP — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||